Head Office
Novartis International AG
CH-4002 Basel
Switzerland
+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)
Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland
+41 61 324 79 44
investor.relations@novartis.com
Global Media Relations
Eric Althoff
Basel, Switzerland
+41 61 324 7999
eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Novartis shareholders can participate in our Direct Share Purchase Plan, which allows the direct purchase of Novartis registered shares at low cost, with automatic reinvestment of dividends in additional Novartis shares.
The Direct Share Purchase Plan is open to shareholders and investors living in Switzerland.
© 2013 Novartis AG Terms of usePrivacy policy Sitemap
